Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 199 of the 202 references it cites were found in a registry or an index.

Alcohol-associated liver disease

Open access
Mackowiak, Bryan, Fu, Yaojie, Maccioni, Luca, Gao, Bin · 2024 · Journal of Clinical Investigation

Abstract

Alcohol-associated liver disease (ALD) is a major cause of chronic liver disease worldwide, and comprises a spectrum of several different disorders, including simple steatosis, steatohepatitis, cirrhosis, and superimposed hepatocellular carcinoma. Although tremendous progress has been made in the field of ALD over the last 20 years, the pathogenesis of ALD remains obscure, and there are currently no FDA-approved drugs for the treatment of ALD. In this Review, we discuss new insights into the pathogenesis and therapeutic targets of ALD, utilizing the study of multiomics and other cutting-edge approaches. The potential translation of these studies into clinical practice and therapy is deliberated. We also discuss preclinical models of ALD, interplay of ALD and metabolic dysfunction, alcohol-associated liver cancer, the heterogeneity of ALD, and some potential translational research prospects for ALD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci176345

Cites

199 of 199 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Spectrum of ALD, risk factors, and comorbidities. Almost all individuals who drink heavily (90%–95%) develop steatosis; some of them may develop more severe forms of ALD, including alcohol-associated steatohepatitis (ASH), cirrhosis, and hepatocellular carcinoma (HCC). Some patients with underlying ALD develop acute alcohol-associated hepatitis (AH) with the typical clinical syndrome jaundice. AH is often referred to as a severe form of AH that has a high short-term morality. ASH is diagnosed based on histology, while AH is diagnosed based on clinical symptoms. Many risk factors promote the development of the severe forms of ALD. Alcohol intake and comorbid factors synergistically promote the progression of ALD. Adapted with permission from Gastroenterology (4).
Figure 1 Spectrum of ALD, risk factors, and comorbidities. Almost all individuals who drink heavily (90%–95%) develop steatosis; some of them may develop more severe forms of ALD, including alcohol-associated steatohepatitis (ASH), cirrhosis, and hepatocellular carcinoma (HCC). Some patients with underlying ALD develop acute alcohol-associated hepatitis (AH) with the typical clinical syndrome jaundice. AH is often referred to as a severe form of AH that has a high short-term morality. ASH is diagnosed based on histology, while AH is diagnosed based on clinical symptoms. Many risk factors promote the development of the severe forms of ALD. Alcohol intake and comorbid factors synergistically promote the progression of ALD. Adapted with permission from Gastroenterology (4).CC BY · PubMed Central
Figure 2 Pathogenesis of and interorgan crosstalk contribution to ALD. Excessive alcohol intake directly induces hepatocellular damage via multiple mechanisms. The crosstalk with several other organs, including brain-liver, gut-liver, and adipose-liver crosstalk, also contributes to ALD pathogenesis. Excessive alcohol consumption profoundly affects the immune system and immune cells, which also contributes to ALD progression. ABD, alcohol-associated bowel disease; AUD, alcohol use disorder; DAMP, damage-associated molecular pattern; PAMP, pathogen-associated molecular pattern; FFA, free fatty acid.
Figure 2 Pathogenesis of and interorgan crosstalk contribution to ALD. Excessive alcohol intake directly induces hepatocellular damage via multiple mechanisms. The crosstalk with several other organs, including brain-liver, gut-liver, and adipose-liver crosstalk, also contributes to ALD pathogenesis. Excessive alcohol consumption profoundly affects the immune system and immune cells, which also contributes to ALD progression. ABD, alcohol-associated bowel disease; AUD, alcohol use disorder; DAMP, damage-associated molecular pattern; PAMP, pathogen-associated molecular pattern; FFA, free fatty acid.CC BY · PubMed Central
Figure 3 Inflammation in ALD. Alcohol-associated steatohepatitis (ASH) is characterized by hepatic infiltration of a large number of inflammatory cells, with predominant neutrophil and macrophage infiltration. Kupffer cells are activated at the early stage of ALD but are markedly reduced in the late stages of ALD, such as cirrhosis. ALD is also associated with infiltration of a significant number of T cells, but their subtypes and functions have not been well characterized. ALD, especially severe AH, is associated with infiltration of B cells and massive antibody deposition. The subsets and functions of inflammatory cells will be likely identified by single-cell and spatial transcriptomics and multiplex immunofluorescent staining analysis over the coming years. ASH is also associated with elevation of a large number of proinflammatory cytokines, chemokines, and adhesion molecules, which have overlapping functions and synergistically promote liver inflammation.
Figure 3 Inflammation in ALD. Alcohol-associated steatohepatitis (ASH) is characterized by hepatic infiltration of a large number of inflammatory cells, with predominant neutrophil and macrophage infiltration. Kupffer cells are activated at the early stage of ALD but are markedly reduced in the late stages of ALD, such as cirrhosis. ALD is also associated with infiltration of a significant number of T cells, but their subtypes and functions have not been well characterized. ALD, especially severe AH, is associated with infiltration of B cells and massive antibody deposition. The subsets and functions of inflammatory cells will be likely identified by single-cell and spatial transcriptomics and multiplex immunofluorescent staining analysis over the coming years. ASH is also associated with elevation of a large number of proinflammatory cytokines, chemokines, and adhesion molecules, which have overlapping functions and synergistically promote liver inflammation.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 202 references

Research works printed but not linked: 1

  1. 10.7554/eLife.86678.2 · DOI

Cited by

See all 361

Metadata

Authors
Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B.
Affiliations
National Institutes of Health (US)
Corresponding author
Gao, Bin
Venue
Journal of Clinical Investigation
Published
2024-02-01
Volume
134
Issue
3
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W4391540982
Cited by
359
References
202
Citations by year
2026: 129 · 2025: 160 · 2024: 70
FWCI
26.80
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
alcoholic liver disease, alcoholic steatohepatitis, alcoholic cirrhosis, pathogenesis, therapeutic target, multi-omics, preclinical models, metabolic dysfunction, disease heterogeneity, translational research
MeSH terms
Ethanol, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver, Liver Cirrhosis, Liver Diseases, Alcoholic, Liver Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alcohol-associated liver disease. https://app.cochat.ai/papers/10.1172/jci176345
The paper
Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B. (2024). Alcohol-associated liver disease. Journal of Clinical Investigation. https://doi.org/10.1172/jci176345

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.